The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 25,954 | 1,529,402 | SH | SOLE | 1,529,402 | 0 | 0 | ||
ACLARIS THERAPEU | COM | 00461U105 | 3,751 | 217,600 | SH | SOLE | 217,600 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 28,149 | 554,000 | SH | SOLE | 554,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | 3,794 | 82,500 | SH | SOLE | 82,500 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 1,890 | 140,030 | SH | SOLE | 140,030 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 3,961 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
BCLS ACQUISITION CORP- CL A | COM CL A | G0904B105 | 8,322 | 843,122 | SH | SOLE | 843,122 | 0 | 0 | ||
BELLUS HEALTH INC | COM NEW | 07987C204 | 5,614 | 816,000 | SH | SOLE | 816,000 | 0 | 0 | ||
CALL- ACIU 100@7 1/2EXP 08/19/2022 | SHS | H00263105 | 400 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
CALL- ATHA 100@12 1/2 EXP 07/15/2022 | COM | 04746L104 | 1,350 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
CALL- PMVP 100 @ 20 EXP 06/17/2022 | COM | 69353Y103 | 2,082 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 10,998 | 322,898 | SH | SOLE | 322,898 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 717 | 37,500 | SH | SOLE | 37,500 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 164 | 2,300 | SH | SOLE | 2,300 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,742 | 307,944 | SH | SOLE | 307,944 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 4,730 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 7,675 | 419,632 | SH | SOLE | 419,632 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 2,473 | 497,500 | SH | SOLE | 497,500 | 0 | 0 | ||
HEALTH SCIENCES ACQUISITIONS | ORD SHS | G4411D109 | 3,890 | 392,500 | SH | SOLE | 392,500 | 0 | 0 | ||
HORIZON THERAPEUTICS PLC | SHS | G46188101 | 3,493 | 33,200 | SH | SOLE | 33,200 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 262 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,979 | 118,856 | SH | SOLE | 118,856 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 9,080 | 539,500 | SH | SOLE | 539,500 | 0 | 0 | ||
JIYA ACQUISITION CORP -CL A | COM CL A | 47760M102 | 5,524 | 562,500 | SH | SOLE | 562,500 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 5,524 | 813,500 | SH | SOLE | 813,500 | 0 | 0 | ||
KURA ONCOLOGY INC. COMMON STOCK | COM | 50127T109 | 7,621 | 473,969 | SH | SOLE | 473,969 | 0 | 0 | ||
MERUS NV | COM | N5749R100 | 6,227 | 235,500 | SH | SOLE | 235,500 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 2,440 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
MIRATI THERAPEUTICS | COM | 60468T105 | 4,317 | 52,500 | SH | SOLE | 52,500 | 0 | 0 | ||
MOLECULAR TEMPLATES INC | COM | 608550109 | 1,060 | 307,125 | SH | SOLE | 307,125 | 0 | 0 | ||
NUVATION WARRANTS | *W EXP 07/07/202 | 67080N101 | 69 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,821 | 135,500 | SH | SOLE | 135,500 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 808 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 9,231 | 342,000 | SH | SOLE | 342,000 | 0 | 0 | ||
SEELOS THERAPEUTICS INC | COM | 81577F109 | 248 | 295,896 | SH | SOLE | 295,896 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,582 | 206,126 | SH | SOLE | 206,126 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 962 | 70,877 | SH | SOLE | 70,877 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 1,406 | 996,951 | SH | SOLE | 996,951 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 6,287 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 14,553 | 11,736,283 | SH | SOLE | 11,736,283 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,878 | 225,000 | SH | SOLE | 225,000 | 0 | 0 |